We have previously demonstrated that CBE protects against high-fat diet (HFD)-induced hepatic steatosis by inhibition of HAT activity in HepG2 cells and HFD-induced obese mouse livers [3], suggesting that CBE acts as an HAT inhibitor. This evidence concerns the gene TMPRSS11D and Hepatic steatosis.